Phase II study of the PI3K inhibitor BKM120 in patients...

British Journal of Cancer 2017 / 1 Vol. 116; Iss. 3

Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I–type II study from the GINECO group

Heudel, P-E, Fabbro, M, Roemer-Becuwe, C, Kaminsky, M C, Arnaud, A, Joly, F, Roche-Forestier, S, Meunier, J, Foa, C, You, B, Priou, F, Tazi, Y, Floquet, A, Selle, F, Berton-Rigaud, D, Lesoin, A, Kalba
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
116
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/bjc.2016.430
Date:
January, 2017
File:
PDF, 262 KB
english, 2017
Conversion to is in progress
Conversion to is failed